3,5-dibromo-2-chlorosalicylanilide-4'-isothiocyanate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 175110 |
| CHEMBL ID | 1998767 |
| MeSH ID | M0094752 |
| Synonym |
|---|
| nsc293061 |
| 72670-62-3 |
| nsc-293061 |
| 3,5-dibromo-2-chlorosalicylanilide-4'-isothiocyanate |
| cdri 77-6 |
| benzamide, 3,5-dibromo-n-(2-chloro-4-isothiocyanatophenyl)-2-hydroxy- |
| 3,5-dibromo-2-chloro-4-isothiocyanatosalicylanilide |
| nsc 293061 |
| compound 77-6 |
| DTXSID20222984 |
| CHEMBL1998767 |
| 3,5-dibromo-2'-chloro-4'-isothiocyanatosalicylanilide |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||